AFP and hepatocellular carcinoma: Despite novel developments in HCC and HB surveillance and monitoring, ultrasound and AFP controls every 3–6 months following Kasai procedure remain the most effective instruments for surveillance, especially learning from strategies in adult cirrhotic patients by global hepatological associations.